Publication | Open Access

Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial

Node-positive Breast CancerBreast OncologyOncologyAdjuvant ChemotherapyGynecologyBreast CancerMenopauseMedicineRadiation OncologyEndocrine-related CancerPhase 3Menopause Hormone Therapy